Chris Ryser
10-25-2006, 09:36 AM
2006 Nine-Month Revenue
Business Firm in Third Quarter
Charenton-le-Pont, France (October 19, 2006) - Essilor, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30, 2006:
€ millions
Sept. 30, 2006
Sept. 30, 2005
Change as reported
Like-for-like change *
Consolidated revenue
2,022.6
1,803.1
12.2%
7.8%
Europe
895.3
833.5
7.4%
6.2%
North America
882.9
764.1
15.6%
9.1%
Asia-Pacific
175.9
149.2
17.9%
10.8%
Latin America
68.5
56.3
21.6%
7.1%
* Based on a comparable scope of consolidation and at constant exchange rates.
Consolidated revenue totaled €2,022.6 million for the period, an increase of 7.8% like-for-like and 12.2% as reported. Companies acquired or consolidated in 2005 and 2006 accounted for 3.2% of the growth, while the currency effect declined but remained slightly positive at 1.1%.
Revenue rose 6.4% in the third quarter. At 6.1%, like-for-like growth remained generally strong, amounting to 6% in Europe and North America, 6.2% in Asia-Pacific and 8.9% in Latin America. Changes in the scope of consolidation accounted for 2.4% of third-quarter growth while the currency effect was a negative 2.1% due to the appreciation of the euro against most other currencies.
Essilor continued to benefit from sustained demand for Varilux Physio®, its new mass-market progressive lens, which is now available in a full range of materials and in all regions. Growth was also driven by other lens categories, in particular variable-tint lenses, high-index materials and anti-reflective lenses.
Strengthened by the successful integration of acquisitions made in recent years, all of the distribution networks also contributed to the Company’s operating performance.
Recent Acquisition
Essilor made 20 acquisitions in the first nine months of 2006. This figure includes the majority stake acquired in Aspen Optical, a Mesa, Arizona-based prescription laboratory that distributes Varilux® products and has annual sales of roughly $6.6 million.
Business Firm in Third Quarter
Charenton-le-Pont, France (October 19, 2006) - Essilor, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30, 2006:
€ millions
Sept. 30, 2006
Sept. 30, 2005
Change as reported
Like-for-like change *
Consolidated revenue
2,022.6
1,803.1
12.2%
7.8%
Europe
895.3
833.5
7.4%
6.2%
North America
882.9
764.1
15.6%
9.1%
Asia-Pacific
175.9
149.2
17.9%
10.8%
Latin America
68.5
56.3
21.6%
7.1%
* Based on a comparable scope of consolidation and at constant exchange rates.
Consolidated revenue totaled €2,022.6 million for the period, an increase of 7.8% like-for-like and 12.2% as reported. Companies acquired or consolidated in 2005 and 2006 accounted for 3.2% of the growth, while the currency effect declined but remained slightly positive at 1.1%.
Revenue rose 6.4% in the third quarter. At 6.1%, like-for-like growth remained generally strong, amounting to 6% in Europe and North America, 6.2% in Asia-Pacific and 8.9% in Latin America. Changes in the scope of consolidation accounted for 2.4% of third-quarter growth while the currency effect was a negative 2.1% due to the appreciation of the euro against most other currencies.
Essilor continued to benefit from sustained demand for Varilux Physio®, its new mass-market progressive lens, which is now available in a full range of materials and in all regions. Growth was also driven by other lens categories, in particular variable-tint lenses, high-index materials and anti-reflective lenses.
Strengthened by the successful integration of acquisitions made in recent years, all of the distribution networks also contributed to the Company’s operating performance.
Recent Acquisition
Essilor made 20 acquisitions in the first nine months of 2006. This figure includes the majority stake acquired in Aspen Optical, a Mesa, Arizona-based prescription laboratory that distributes Varilux® products and has annual sales of roughly $6.6 million.